The Advances in Blood and Marrow Transplantation (BMT) Symposium is an annual conference sponsored by The University of Kansas Cancer Center Blood and Marrow Transplant Program, National Marrow Donor Program "Be the Match", and the University of Kansas Medical Center's Area Health Education Center. The conference offers a review of the latest advances in the field of autologous and allogeneic transplantation including, current state-of-the-art treatment strategies, clinical trials research and outcomes of both autologous and allogeneic (related and unrelated donor) transplants to aid in your clinical decision making.
More info will be posted as it becomes available.
Speakers are listed in the order in which they appear on the agenda. Information will be updated as it is received.
|Joseph McGuirk, D.O.
Professor of Medicine, Speas/Schutte Endowed Professor in Hematologic Malignancies, Division Director, Hematologic Malignancies and CellularTherapeutics, Medical Director, Blood and Marrow Transplantation
Joseph McGuirk received a DO from the University of Osteopathic Medicine, Kansas City, MO and completed an internal medicine internship and residency and a psychiatric residency at the Yale-New Haven Hospital, New Haven, CT. Dr. McGuirk also completed a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center. He is currently professor of medicine; Medical Director, Blood and Marrow Transplantation and Interim Director, Hematology/Oncology at the University of Kansas Medical Center.
|Parameswaran Hari, MBBS, MD, MRCP, MS
Section Head, Hematological Malignancies and Adult Bone Marrow Transplant Program;Medical College of Wisconsin, Milwaukee; Scientific Director, CIBMTR Plasma Cell Disorders and Adult Solid Tumors Working CommitteeParameswaran Hari, MD, MRCP, MS, is the Armand J. Quick/William F. Stapp Professor of Hematology at Medical College of Wisconsin. Dr. Hari serves as Director of the Adult Blood and Marrow Transplant Program (BMT) at Froedtert Hospital and Section Head, Hematologic Malignancies and Transplantation, in the Division of Hematology and Oncology in the Department of Medicine. After medical school in India, he completed training in Internal Medicine and Hematology at premier institutions in United Kingdom and then in Medical Oncology and Transplantation at the Medical College of Wisconsin. His primary clinical interests are in allogeneic hematopoietic stem cell transplantation, plasma cell disorders -- multiple Myeloma, Amyloidosis and other monoclonal gammopathies. Dr. Hari is also Scientific Director of the plasma cell disorders and lymphoma working committees of the Center for International Blood and Marrow Transplant Research (CIBMTR).
|Linda Burns, M.D.
Vice President and Medical Director, Health Services Research, National Marrow Donor Program® (NMDP)/Be The Match®Dr. Burns received her MD from the University of Missouri-Columbia in 1981. She then completed a residency and chief residency in internal medicine, followed by a fellowship in hematology/oncology at the University of Iowa.
From 1992 to 2014, Dr. Burns was a member of the Adult Blood and Marrow Transplant Program at the University of Minnesota where she was Professor of Medicine. Dr. Burns also served as the inpatient BMT Medical Director and Director of the Institutional Site Specific Teams for the Masonic Cancer Center, as well as the fellowship program director for her division. She is the only three-time awardee of the Division of Hematology, Oncology and Transplantation academic mentor award, the 2012 recipient of the Eric G. Neilson, MD Distinguished Professor Award from the Association of Specialty Professors, received the 2013 Distinguished Service Award from the University of Missouri-Columbia, served as a Director of the American Society for Blood and Marrow Transplantation from 2010-2013, and served as the President of the American Society of Hematology in 2014. In December 2014, Dr. Burns joined the National Marrow Donor Program/Be The Match, where she is the Medical Director of Health Services Research. Dr. Burns is a former ASH President and an editor of the current edition of Williams Hematology, published by McGraw-Hill in December 2015.
|Christopher Bredeson, MD, MSc, FRCPC
Head, Malignant Hematology and Stem Cell Transplantation, Division of Hematology Ottawa HospitalDr. Christopher Bredeson received a medical degree (cum laude) from the University of Ottawa. His post-doctorate training included an internship and residency in internal medicine at The Ottawa Hospital, as well as a residency in clinical hematology and a fellowship in the Leukemia/Bone Marrow Transplant Program at the University of British Columbia in Vancouver. He holds a Masters degree in Clinical Epidemiology also from the University of Ottawa.
Dr. Bredeson returned to Ottawa in 2011 after a decade at the Medical College of Wisconsin where he was a Scientific Director at the Center for International Blood and Marrow Transplant Research. While there he participated in the establishment of the NIH funded Blood and Marrow Transplant Clinical Trials Network and designed and ran several of their early trials. Dr. Bredeson returned to Ottawa to run the Malignant Hematology and Stem Cell Transplantation Programme at The Ottawa Hospital.
Dr Bredeson is a Professor in the Faculty of Medicine and Senior Scientist at the Ottawa Hospital Research Institute.
|Navneet Majhail, MD, MS
Director, Blood and Marrow Transplant Program, Professor of Medicine, Cleveland ClinicDr. Majhail received his medical degrees from Government Medical College, Chandigarh, India and the All India Institute of Medical Sciences, New Delhi, India. He completed a residency in internal medicine at the Cleveland Clinic Foundation, and a fellowship in hematology‐oncology at the University of Minnesota. He also obtained an MS in Clinical Research from the University of Minnesota. His research interests include survivorship issues and late effects of transplantation and health services research in hematologic malignancies and blood and marrow transplantation.
|Siddhartha Ganguly, M.D.
Director, Lymphoma and Myeloma, Blood and MarrowTransplantation, Professor of MedicineSiddartha Ganguly received a MD from the Institute of Medical Education and Research, Chandigarh, India; completed an internship at Southern Illinois University School of Medicine and a residency in internal medicine, fellowship in hematology and a fellowship in bone marrow transplantation at Baylor College of Medicine, Houston, Texas. Dr. Ganguly is currently Professor Medicine and Director, Lymphoma/Myeloma program at the University of Kansas Medical Center.
|Elizabeth M. Muenks, Ph.D.
Assistant Professor, Onco-Psychology Service, Department of Psychiatry and Behavioral Sciences, The University of Kansas Medical CenterDr. Muenks obtained her Bachelor of Science degree in Psychology from the University of Wisconsin-LaCrosse (2001-2005) followed by her Master of Arts in Clinical Psychology (2005-2008) from Washburn University in Topeka, Kansas. She then completed her Doctor of Philosophy in Clinical Psychology (2009-2013) at Saint Louis University where she received a graduate diversity fellowship. She attended an APA accredited internship at the University of Wisconsin-Madison (2012-2013), completing a generalist track, with a focus on integrated primary care and cancer psychology. Dr. Muenks then completed a Psycho-Oncology Post-Doctoral Fellowship at the Alvin J. Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis (2013-2014). She joined the faculty at the University of Kansas Medical Center in Summer 2016. Dr. Muenks is a member of the American Psychological Association (APA) and their Health Psychology Division as well as the American Psychosocial Oncology Society (APOS). Dr. Muenks has research and clinical experience in diversity-related topics, minority psychology issues and multiculturally competent practice. She is also interested in how those areas are considered within psychotherapy and medical center culture and practice. Dr. Muenks is passionate about the development of diversity training for students, faculty and staff alike. Currently, Dr. Muenks provides clinical services to cancer patients and their caregivers, with expertise in the presenting concern and challenges of patients seen in the KU Cancer Center Blood and Marrow Transplant program. Her clinical interests in existential concerns, quality of life, cancer survivorship, sleep disturbance and the connection between physical and psychological health are important aspects of her clinical work with the oncology population at KUMC.
|Meagan L. Dwyer, Ph.D.
Clinical Assistant Professor, Psycho-Oncology Service, Department of Psychiatry and Behavioral Sciences, The University of Kansas Medical Center
Dr. Dwyer completed her Doctor of Philosophy in Clinical Psychology (2006-2010) at Saint Louis University. She attended an APA accredited internship at the Southeast Louisiana Veterans Health Care System in New Orleans, LA (2009-2010), with a focus on behavioral medicine and empirically supported treatments for PTSD. Dr. Dwyer then became the Psycho-Oncology Post-Doctoral Fellow at the Alvin J. Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis (2010-2011). Dr. Dwyer is a member of the American Psychological Association (APA) and the American Psychosocial Oncology Society (APOS). Dr. Dwyer has research and clinical experience and interests focused on trauma/PTSD and health psychology, particularly oncology. She is also interested in end-of-life issues, quality of life, and the interrelationships between psychological and physical health. Dr. Dwyer has expanded research into professional practice topics, particularly the impact of healthcare-related work on professional providers and training and program development within psycho-oncology. She is also engaged in adapting and developing distress screening for both academic and clinical application. Dr. Dwyer serves as Director of the Onco-Psychology program. She provides services to cancer patients and their families, with a particular focus on patients within the KU Cancer Center Blood and Marrow Transplant program. She practices within the areas of psychotherapy and psychological assessment with a focus on empirically supported treatments for psychiatric disorders within the context of adult health psychology.
|Tara Lin, M.D.
Assistant Professor, Division of Hematologix Malignancies and Cellular Therapeutics, The University of Kansas Medical CenterDr. Lin completed medical school at the Medical College of Virginia/Virginia Commonwealth University in Richmond, Va. Her clinical interest lies in acute leukemia and her research interest is in novel therapies in relapsed acute leukemia and cancer stem cell targeted therapies.
|Mary Luder, APRN
Outpatient Bone Marrow Transplant, The University of Kansas HospitalMary Luder earned her Masters in Nursing in 2004 from the University of Kansas Medical Center. She has spent the last six years at The University of Kansas Hospital where he has been responsible for the day-to-day care of acute and chronic hematologic patients going through transplant, bone marrow biopsies, intrathecal chemotherapy through lumbar tap and omaya shunt, admissions, lab review, graph vs. host assessments, research participation, and long-term follow-ups.
|Stephanie Hammontree, RN, MSN, OCN
Outpatient BMT Unit Educator, Blood and Marrow Transplantation Program, The University of Kansas Medical CenterStephanie Hammontree earned her masters degree in nursing education from MidAmerica Nazarene University in 2013. She has worked for the University of Kansas Cancer Center since 2010. In 2014, Hammontree began her current role as a Unit Educator.
|Sunil Abhyankar, M.D.
Medical Director, Pheresis and Cell Processing, Blood and Marrow Transplantation, Professor of MedicineSunil Abhyankar received a MD from the University of Bombay. Dr. Abhyankar was a pediatric hematology/oncology fellow at State University of New York; a Bone Marrow Transplant fellow at Memorial Sloan-Kettering and a research fellow, Bone Marrow Transplantation at Dana Farber Cancer Institute. He is currently Professor of Medicine and Director-Pheresis and Cell Processing at the University of Kansas Medical Center.
All participants are required to complete and sign a verification of attendance form. After the program, a certificate of completion will be provided to activity participants based on documentation of actual attendance time.
Physicians: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Kansas Medical Center Office of Continuing Medical Education, KUCC BMT Program and National Marrow Donor Program. The University of Kansas Medical Center Office of Continuing Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
The KU Medical Center Office of Continuing Medical Education designates this live activity for a maximum of 5.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: The University of Kansas Medical Center Area Health Education Center West, as an approved provider of continuing education by the Kansas State Board of Nursing, presents this offering for 6.3 contact hours credit applicable for relicensure of RNs and LPNs. Kansas Provider Number LT0086-1149. Karen Aufdemberge, BSN, RN, coordinator. Continuing education credit will be prorated according to documented attendance.
APRNs: The University of Kansas Medical Center Area Health Education Center West, as an approved provider of continuing education by the Kansas State Board of Nursing, presents this offering for 6.3 contact hours credit applicable for relicensure of APRNs. Kansas Provider Number LT0086-1149. Karen Aufdemberge, BSN, RN, coordinator. Continuing education credit will be prorated according to documented attendance.
The Sheraton Hotel next to the Overland Park Convention Center will host accommodations for the symposium. For the special rate, specify that you are part of the University of Kansas Medical Center BMT Symposium. Reservations must be made no later than April 8, 2017, by calling toll-free 866-837-4214 or visiting www.sheraton.com/overlandpark.